作者
Edward Pivin, Belen Ponte, Sophie de Seigneux, Daniel Ackermann, Idris Guessous, Georg Ehret, Antoinette Pechère-Bertschi, Eric Olinger, Markus Mohaupt, Bruno Vogt, Pierre-Yves Martin, Michel Burnier, Murielle Bochud, Olivier Devuyst, Menno Pruijm
发表日期
2018/10/1
期刊
Clinical Journal of the American Society of Nephrology
卷号
13
期号
10
页码范围
1556-1557
出版商
LWW
简介
Every human is born with a certain number of nephrons. Assessing that number (ie, nephron mass) is important because a low nephron mass at birth is a risk factor for hypertension and/or CKD. A reduced number of nephrons leads to hyperfiltration in the remaining ones, increasing intraglomerular pressure and, in the long term, glomerulosclerosis (1). This mechanism explains why kidney function may continue to decline in patients with CKD even when the primary insult is gone. Unfortunately, estimating nephron mass is not currently possible without kidney biopsy studies. The level of uromodulin (Tamm-Horsfall protein) in urine is a candidate to estimate nephron mass because the protein is synthesized by the thick ascending limb of the loop of Henle and is essentially released into the urine. We hypothesized that if urinary uromodulin is a proxy of nephron mass, then (1) it should be associated with the known …
引用总数
201920202021202220232024812111645
学术搜索中的文章
E Pivin, B Ponte, S de Seigneux, D Ackermann… - Clinical Journal of the American Society of Nephrology, 2018